Type Whole antibody Target beta-amyloid CAS Number 1178862-65-1 | Source Humanized (from mouse) ATC code none ChemSpider none | |
Ponezumab is a humanized monoclonal antibody designed for the treatment of Alzheimer's disease.
Ponezumab was developed by Pfizer Inc. In November 2011 Pfizer halted the development of ponezumab after finishing a phase 2 trial. Detailed reports have to be released.
References
Ponezumab Wikipedia(Text) CC BY-SA